LWMI
ABBV icon

Legacy Wealth Management (Idaho)’s AbbVie ABBV Stock Holding History

Legacy Wealth Management (Idaho)’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-168
Closed -$36.5K – 199
2026
Q1 		$36.5K Buy
168
+32
+24% +$7.1K 0.02% 312
2025
Q4 		$31.1K Buy
136
+73
+116% +$16.6K 0.01% 277
2025
Q3 		$14.5K Buy
63
+5
+9% +$1.02K 0.01% 303
2025
Q2 		$10.8K Hold
58
– – 0.01% 305
2025
Q1 		$12.2K Buy
58
+50
+625% +$9.72K 0.01% 302
2024
Q4 		$1.52K Sell
8
-69
-90% -$12.7K ﹤0.01% 539
2024
Q3 		$13.1K Buy
+77
New +$14.4K 0.01% 268

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Legacy Wealth Management (Idaho)'s ABBV Position: Q2 2026 in Review

Legacy Wealth Management (Idaho) sold out of AbbVie (ABBV) in Q2 2026, closing a stake of 168 shares — an estimated $36.5K sold.

Legacy Wealth Management (Idaho) first reported a position in ABBV in Q3 2024 and held it in 7 quarters. The position peaked at $36.5K in Q1 2026. 4,188 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Legacy Wealth Management (Idaho) reported no remaining AbbVie position as of Q2 2026 after selling out during the quarter.
  • Legacy Wealth Management (Idaho) sold 168 AbbVie shares in Q2 2026, an estimated $36.5K.
  • Legacy Wealth Management (Idaho) first reported a position in AbbVie in Q3 2024 and held it in 7 quarters.
  • Legacy Wealth Management (Idaho)'s AbbVie position peaked at $36.5K in Q1 2026.
  • 4,188 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Legacy Wealth Management (Idaho)'s 13F filing for Q2 2026, filed 13 Aug 2026.